- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01346631
The Paleolithic Diet and Male Factor Infertility
June 21, 2015 updated by: HaEmek Medical Center, Israel
The Impact of a Paleolithic Diet on Sperm Parameters for Men Suffering From Male Infertility
Prospective studies concerning diet and male fertility are lacking.
Observational studies suggest that a diet rich in fruits, vegetables and meats may be associated with higher sperm counts.
The investigators wanted to see if a "paleolithic diet" consisting of meat, fish, fruits vegetables and nuts and lacking grains, legumes and dairy products can improve sperm counts.
Study Overview
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Afula, Israel
- HaEmek Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- men with male infertility
- willingness to make dietary change for three months
- willingness to be blinded to sperm test results until the end of the experiment
Exclusion Criteria:
- High fever or abdominal or scrotal surgery during three months prior to intervention
- Change in diet, drinking or smoking habits in three months prior to intervention
- regular consumption of more than two servings of alcohol a day
- background ailment preventing dietary change
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: paleolithic diet
Subjects will adhere to a paleolithic diet for the duration of three months
|
The diet consists of unlimited quantities of meat and fish, fruits and vegetables, eggs, nuts and water.
Foods to be avoided include grains, wheat products, legumes, soy, potatoes and corn, rice, legumes, processed meats, soft drinks, dairy products and sugar.
Allowed in moderation include coffee, alcohol,cooking oil, honey, salt, dried fruit.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sperm Parameters
Time Frame: 3 months
|
volume, concentration, motility, morphology
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Biomedical Indexes
Time Frame: 3 months
|
Weight, blood pressure, CBC, liver enzymes, kidney function, lipid prophile, fasting glucose, HgbA1c, CRP, Testosterone, LH, FSH, Estradiol, TSH, Prolactin.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2011
Primary Completion (Anticipated)
May 1, 2012
Study Completion (Anticipated)
May 1, 2012
Study Registration Dates
First Submitted
May 1, 2011
First Submitted That Met QC Criteria
May 2, 2011
First Posted (Estimate)
May 3, 2011
Study Record Updates
Last Update Posted (Estimate)
June 23, 2015
Last Update Submitted That Met QC Criteria
June 21, 2015
Last Verified
June 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0130-10-EMC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Male Infertility
-
Medipol UniversityNot yet recruitingMale Infertility | Unexplained Infertility | Sperm DNA Fragmentation
-
Szeged UniversityEnrolling by invitation
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
South Valley UniversityActive, not recruitingMale Infertility | OligoasthenozoospermiaEgypt
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Fecundis Lab SLRecruitingMale Infertility | Reproductive Issues | ICSI | Infertility (IVF Patients) | IVF OutcomesSpain
-
Jinling Hospital, ChinaRecruitingMale Infertility Due to HypospermatogenesisChina
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
University of Medicine and Pharmacy at Ho Chi Minh...RecruitingMale Infertility With OATVietnam
-
Reproductive Medicine Associates of New JerseyTerminated
Clinical Trials on paleolithic diet
-
Lund University HospitalCompletedDiabetes Mellitus, Type 2Sweden
-
Lund University HospitalCompletedHyperglycemia | Coronary Heart DiseaseSweden
-
Johns Hopkins UniversityCompletedIrritable Bowel SyndromeUnited States
-
Assiut UniversityNot yet recruitingCrohn Disease | Ulcerative Colitis | Nutrition
-
Lund University HospitalRegion SkaneWithdrawn
-
Umeå UniversityCompleted
-
Kasr El Aini HospitalRecruitingRheumatoid Arthritis (RA)Egypt
-
Assiut UniversityNot yet recruitingDiabetic PatientsEgypt
-
Umeå UniversityCompletedDiabetes Mellitus, Type 2Sweden
-
Amanda IrishCompletedMultiple Sclerosis, Relapsing-remittingUnited States